Clinical Trial Update: A Study to Evaluate the Safety and Effectiveness of Doxercalciferol Capsules in Participants With Moderate to Severe Psoriasis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety and effectiveness of doxercalciferol capsules in participants with moderate to severe chronic plaque psoriasis has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis
• Psoriasis

Drugs mentioned

• DOXERCALCIFEROL (Doxercalciferol)

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Moderate to Severe Chronic Plaque Psoriasis | Phase 2 | Status: COMPLETED | Results posted: 2014-05-05